Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05179369Not ApplicableActive Not Recruiting

Well-Mama Community Doula Navigator Study

Role: collaborator

NCT03842995Not ApplicableCompleted

South-seq: Deoxyribonucleic Acid (DNA) Sequencing for Newborn Nurseries in the South

Role: collaborator

NCT02208011Completed

A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes

Role: collaborator

NCT04139694Not ApplicableWithdrawn

Improving Insulin Resistance in Gynecological Cancer Patients

Role: collaborator

All 4 trials loaded